Author

Avery Bodlak

University of Colorado AnschutzORCID 0000-0001-9207-1532Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexis B. DuffyiD· 1 shared Amy Treece· 1 shared Andrew E. GoodspeediD· 1 shared Brian S. GreffeiD· 1 shared Carrye Rudolph CostiD· 1 shared Daniel L. AdamsiD· 1 shared Deandra WalkeriD· 1 shared Etienne P. DanisiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexis B. DuffyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyClinical Cancer ResearchPeer-reviewedMar 3, 2025

Characterization of transcriptional heterogeneity and novel therapeutic targets using single cell RNA-sequencing of primary and circulating Ewing sarcoma cells.

Andrew E. Goodspeed, Avery Bodlak, Alexis B. Duffy…·Masanori Hayashi

This study uses single-cell RNA-sequencing to analyze transcriptional heterogeneity in Ewing sarcoma and identifies TSPAN8 as a novel therapeutic target.

21 citationstop 2%

humanscRNA-seq

𝕏 PostBluesky